CD274 and neoplasm: In defining the PD-1/PD-L1 (104) interaction and CTLA-4/CD80/86 (105), the search for novel immune checkpoints broadened into identifying new mechanisms that keep the adaptive immune cell out of the tumor environment and immunologically ignorant (2).